192 related articles for article (PubMed ID: 15356077)
21. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.
Hellerstein MK; Neese RA; Linfoot P; Christiansen M; Turner S; Letscher A
J Clin Invest; 1997 Sep; 100(5):1305-19. PubMed ID: 9276749
[TBL] [Abstract][Full Text] [Related]
22. Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia.
Bischof MG; Bernroider E; Krssak M; Krebs M; Stingl H; Nowotny P; Yu C; Shulman GI; Waldhäusl W; Roden M
Diabetes; 2002 Jan; 51(1):49-54. PubMed ID: 11756322
[TBL] [Abstract][Full Text] [Related]
23. Ethanol stimulates glycogenolysis and inhibits both glycogenesis via gluconeogenesis and from exogenous glucose in perfused rat liver.
Mokuda O; Tanaka H; Hayashi T; Ooka H; Okazaki R; Sakamoto Y
Ann Nutr Metab; 2004; 48(4):276-80. PubMed ID: 15331888
[TBL] [Abstract][Full Text] [Related]
24. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
25. Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas.
Stingl H; Schnedl WJ; Krssak M; Bernroider E; Bischof MG; Lahousen T; Pacini G; Roden M
J Clin Endocrinol Metab; 2002 Oct; 87(10):4678-85. PubMed ID: 12364458
[TBL] [Abstract][Full Text] [Related]
26. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers.
Ghanaat F; Tayek JA
Metabolism; 2005 May; 54(5):604-9. PubMed ID: 15877290
[TBL] [Abstract][Full Text] [Related]
28. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
29. Impaired stimulation of gluconeogenesis during prolonged hypoglycemia in intensively treated insulin-dependent diabetic subjects.
Caprio S; Napoli R; Saccà L; Tamborlane WV; Sherwin RS
J Clin Endocrinol Metab; 1992 Oct; 75(4):1076-80. PubMed ID: 1400874
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
31. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
[TBL] [Abstract][Full Text] [Related]
32. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
33. Substrate source utilization during moderate intensity exercise with glucose ingestion in Type 1 diabetic patients.
Robitaille M; Dubé MC; Weisnagel SJ; Prud'homme D; Massicotte D; Péronnet F; Lavoie C
J Appl Physiol (1985); 2007 Jul; 103(1):119-24. PubMed ID: 17431081
[TBL] [Abstract][Full Text] [Related]
34. Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.
Hwang JH; Perseghin G; Rothman DL; Cline GW; Magnusson I; Petersen KF; Shulman GI
J Clin Invest; 1995 Feb; 95(2):783-7. PubMed ID: 7860761
[TBL] [Abstract][Full Text] [Related]
35. Gluconeogenesis and glycogenolysis in health and diabetes.
Boden G
J Investig Med; 2004 Sep; 52(6):375-8. PubMed ID: 15612450
[TBL] [Abstract][Full Text] [Related]
36. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.
Turk D; Alzaid A; Dinneen S; Nair KS; Rizza R
J Clin Invest; 1995 Feb; 95(2):755-62. PubMed ID: 7860757
[TBL] [Abstract][Full Text] [Related]
37. Effect of gender on counterregulatory responses to euglycemic exercise in type 1 diabetes.
Galassetti P; Tate D; Neill RA; Morrey S; Davis SN
J Clin Endocrinol Metab; 2002 Nov; 87(11):5144-50. PubMed ID: 12414885
[TBL] [Abstract][Full Text] [Related]
38. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
Tappy L
Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
[TBL] [Abstract][Full Text] [Related]
39. Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.
Roden M; Petersen KF; Shulman GI
Recent Prog Horm Res; 2001; 56():219-37. PubMed ID: 11237214
[TBL] [Abstract][Full Text] [Related]
40. Gluconeogenesis and hepatic glycogenolysis during exercise at the lactate threshold.
Emhoff CA; Messonnier LA; Horning MA; Fattor JA; Carlson TJ; Brooks GA
J Appl Physiol (1985); 2013 Feb; 114(3):297-306. PubMed ID: 23239870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
